INTRODUCTION
============

Cryptococcosis as a rule is a systemic mycosis, more frequently seen in patients with AIDS. It is the third most frequent opportunistic disease of the central nervous system (CNS) in this population. It can also be found in other conditions, such as patients with neoplasms, and can present a benign course[@B03]. The disease is rare in immunocompetent individuals, but there are reports of cases[@B06]. Its prevalence ranges from 2.9 to 13.3% in most countries, however it reaches 30% in Africa as well as in Southeast Asia countries. It represents an important cause of mortality in AIDS patients even with specific treatment.

It is estimated that there are 957,900 cases of cryptococcosis worldwide per year[@B11]. Most cases are diagnosed as insidious meningoencephalitis with fever. Others (50% of the cases) present fever, headache, vomiting and altered mental status. Lack of specificity of clinical manifestations delays the diagnosis and worsens the prognosis[@B11].

We present a fatal case of disseminated cryptococcosis in a young man whose diagnosis of HIV infection was made at the time of admission to the emergency room.

CASE REPORT
===========

A twenty-three-year-old man was admitted to the emergency room of an infectious disease hospital in Northeast Brazil with a one-month history of daily fever associated to diarrhea with mucus and weight loss of fifteen kilograms in six months. One week prior to admission, the patient\'s clinical picture worsened with headache, vomiting, disorientation and generalized tonic-clonic seizures. The patient also had a history of diabetes mellitus, tobacco smoking, alcoholism and drug addiction. He had no prior history of hospitalization. Upon physical examination the patient was pale, disoriented, and had periods of agitation. He had rhonchi on the pulmonary auscultation. Abdomen was tender on palpation of the upper right quadrant, liver and spleen were not palpable and no edema was seen in the lower extremities. Nuchal rigidity and meningeal irritation signs were present, however motor deficit was not identified.

Laboratory tests upon admission showed hemoglobin 10 g/dL, 3,440 leukocytes/mm[@B03], (4% bands, 45% neutrophils, 5% lymphocytes), 83,000 platelets/mm[@B03], urea was 19 mg/dL, creatinine 0.7 mg/dL, ionic calcium 1.23 mEq/L, sodium 130 mEq/L, potassium 4.2 mEq/L, and liver enzymes (ALT and AST) were within normal limits; lactic dehydrogenase was 494 IU/L. Cerebrospinal fluid (CSF) analysis revealed 10 white blood cells/mm[@B03] (58% neutrophils, 31% lymphocytes, 11% monocytes) and 2 red blood cells/mm[@B03]. CSF glucose was 122 mg/dL and protein 36 mg/ dL. India ink test revealed six *Cryptococcus* yeasts/mm[@B03]. VDRL test was negative and anti-HIV test positive. CD4 count was 40/mm[@B03]. Blood glucose was 344 mg/dL. Intravenous hydration, insulin, phenytoin, fluconazole, pyrimethamine, sulfadiazine, folinic acid, and amphotericin B were started. The patient did not improve and became obtunded and hypotensive. He was then intubated and put on mechanical ventilation. Arterial blood gases after intubation: pH 7.52, PaCO~2~ 28.9 mmHg, HCO~3~ 26.6 mmEq/L, PaO~2~ 77.9 mmHg, SaO~2~ 96.6% and FiO~2~70%. Vasoactive drugs were added and the patient died less than 24 hours after admission. A post-mortem examination was performed and revealed disseminated cryptococcosis. The histopathology of the kidneys revealed severe renal involvement with *Cryptococcus*sp. in the glomerulus and interstitium ([Fig. 1](#f01){ref-type="fig"}).

Fig. 1Main renal findings. **(a)** Renal biopsy showing numerous encapsulated yeast forms (*Cryptococcus* sp.) in glomerulus, interstitium and in **(b)** renal tubule (black arrow). PAS 400x.

DISCUSSION
==========

We presented a fatal case of cryptococcosis, in which the patient only sought medical attention a month after symptoms\' onset. In a prospective study in Brazil, from 1998 to 2003, 96 cases of cryptococcosis were diagnosed microbiologically and 78 (81.25%) had AIDS[@B04]. Cryptococcosis was diagnosed by direct microscopy in 98.3% of cases, however the culture revealed *Cryptococcus* in 100%. The latex agglutination test is considered a very sensitive and specific technique in the detection of this fungus in CSF. It can be used to monitor treatment as well as in diagnosing relapses after an seemingly successful therapy. In a Brazilian study, despite appropriate treatment, 70 patients died (72.9%); 60 (62.5%) of these deaths occurred in AIDS patients, demonstrating that this systemic mycosis is accompanied by a very high mortality[@B04]. In another cohort of patients with cryptococcosis, in Thailand, favorable clinical response was observed in 55.2% of cases, and the six month survival rate was 67.2%[@B02]. Even in immunocompetent individuals, mortality due to cryptococcal infection can be as high as 51%[@B08]. Our patient had diabetes mellitus, which seems to be a risk factor for developing disseminated cryptococcosis due to defects in the host defense mechanisms associated with hyperglycemia[@B09]. A recent study highlighted possible mechanisms to explain the pathophysiology of HIV-associated cryptococcosis. It was demonstrated that high levels of fungal uptake by macrophages *in vitro*, but not the intracellular proliferation rate, were associated with cerebrospinal fluid fungal burden and long-term patient survival. Highuptake strains were hypocapsular and exhibited enhanced laccase activity. Fungal isolates with greater laccase activity exhibited heightened survival *ex vivo* in purified CSF and resistance to clearance following the patient antifungal treatment[@B12].

There is little data published on kidney involvement in cryptococcosis. This case report illustrates the presence of *Cryptococcus* in the glomerulus, interstitium and renal tubules. As the disease had a rapid and fatal course,

there was no specific clinical or laboratory manifestation of kidney involvement, only the unquestionable presence of *Cryptococcus* in kidney histopathology. Kidney involvement in cryptococcosis is rarely described. The fungus has already been isolated in the urine of HIV-infected patients, evidencing its tropism to the kidneys[@B07]. In a recent study of 49 patients with cryptococcosis and without HIV, acute kidney injury was seen in 47% of cases[@B08]. BOLLÉE *et al.* [@B01] reported the case of an HIV-infected patient with acute kidney injury due to disseminated cryptococcosis, which was successfully treated with plasma exchange therapy. This patient has also developed nephrotic range proteinuria, which evidenced glomerular involvement in cryptococcosis[@B01]. RAMDIAL *et al.* [@B10] described the cases of two HIV-infected children with cryptococcosis complicated by renal involvement. Renal biopsy showed cryptococcal-associated immune reconstitution inflammatory syndrome in one of these patients based on the clinicopathological profile and the presence of segmental glomerular and an interstitial lymphoplasmacytic and granulomatous reaction to *Cryptococcus neoformans*, with predominance of capsuledeficient fungal forms. The other patient presented typical HIV-associated nephropathy with focal intra-tubular and interstitial *C. neoformans*yeasts in renal biopsy[@B10]. The exact pathophysiology of kidney involvement in cryptococcosis remains unclear.

Recommendations for specific treatment of cryptococcal meningoencephalitis can be found in the Brazilian cryptococcosis guidelines[@B05]. According to the guidelines, treatment should initiate with 0.7 to 1.0 mg/kg/day of amphotericin B (maximum 50 mg), associated with 5-flucytosine in a dose of 100 mg/kg/day, given for two weeks as induction treatment. After this period, oral fluconazole 400 mg/day is indicated, for 10 weeks, as a maintenance therapy[@B05]. It is possible that the use of other antifungal agents, such as voriconazole or posaconazole, could change this fatal outcome, particularly in immunosuppressed patients, as *in vitro* studies have demonstrated an excellent effect of these drugs on this fungus[@B11].

In the present case, the disease severity and the fast evolution to death in less than 24 hours after hospital admission did not allow appropriate treatment, started with fluconazole.

In conclusion, cryptococcosis is a systemic mycosis that affects immunocompromised patients, with a high frequency among HIVinfected individuals, mainly those who develop AIDS. It presents as a severe disease with high mortality, especially when the diagnosis is delayed.
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